Toleranzia is enthusiastic about the possibility of collaborating with external industrial and academic partners as a way to develop new therapies in autoimmune diseases.

If you have a collaborative idea that you want to discuss with us, please contact: Björn Löwenadler, Chief Business Officer at Toleranzia, at or submit your idea to